5.Infliximab for the Treatment of Refractory Kawasaki Disease: A Nationwide Survey in Japan.

Masuda H, Kobayashi T, Hachiya A, Nakashima Y, Shimizu H, Nozawa T, Ogihara Y, Ito S, Takatsuki S, Katsumata N, Suzuki Y, Takenaka S, Hirono K, Kobayashi T, Suzuki H, Suganuma E, Takahashi K, Saji T

Research output: Contribution to journalArticlepeer-review

Original languageJapanese
Pages (from-to)115-120.e3
JournalJ Pediatr.
Volume-
DOIs
StatePublished - 2017
Externally publishedYes

Cite this